Patricia Spera

Patricia Spera is an accomplished professional with extensive experience in clinical development and operations, currently serving as Vice President at Invea Therapeutics since November 2021. Previously, Patricia held the position of Director of Global Clinical Sciences at Gan & Lee Pharmaceuticals, where contributions included leading programs for Type II diabetes products. At Nabriva Therapeutics AG, Patricia was the Clinical Lead for a Phase 3 global registration study for an antibacterial compound. Prior roles at GSK included Director of Clinical Development for Cardiovascular and Metabolic Medicine, overseeing significant clinical trials and authoring regulatory documents, and a progressive series of positions that reflected strong leadership in clinical research and development. Patricia earned a Ph.D. in Physiology from Temple University and a Bachelor's degree in Biology from the University of Delaware.